HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 9 of 19

‹View Table of Contents

Related Pages

Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type, Adults, 2018-2021

Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type, Adults, 2018-2021
All SSIs Superficial Incisional Deep Incisional1 Organ/Space2
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank
Staphylococcus aureus 33,201 15.4 1 11,789 18.4 1 9,563 26.4 1 11,849 10.3 2
Escherichia coli 29,874 13.9 2 7,452 11.6 2 3,216 8.9 3 19,206 16.6 1
Enterococcus faecalis3 16,871 7.8 3 5,082 7.9 5 2,299 6.4 5 9,490 8.2 3
Coagulase-negative staphylococci 14,844 6.9 4 5,552 8.7 3 3,595 9.9 2 5,697 4.9 7
Pseudomonas aeruginosa 13,160 6.1 5 5,360 8.4 4 2,414 6.7 4 5,386 4.7 8
Select Klebsiella spp. 11,693 5.4 6 3,703 5.8 6 1,673 4.6 7 6,317 5.5 5
Bacteroides spp. 10,316 4.8 7 1,781 2.8 9 717 2.0 11 7,818 6.8 4
Enterobacter spp. 9,313 4.3 8 3,148 4.9 7 1,884 5.2 6 4,281 3.7 11
Candida albicans3 7,782 3.6 9 1,383 2.2 10 510 1.4 13 5,889 5.1 6
Viridans group streptococci 6,594 3.1 10 1,358 2.1 12 723 2.0 10 4,513 3.9 9
Proteus spp. 6,229 2.9 11 2,707 4.2 8 1,438 4.0 8 2,084 1.8 13
Enterococcus faecium3 6,150 2.9 12 1,153 1.8 14 593 1.6 12 4,404 3.8 10
Other Enterococcus spp.3 5,162 2.4 13 1,363 2.1 11 474 1.3 16 3,325 2.9 12
Citrobacter spp. 3,057 1.4 14 912 1.4 15 409 1.1 17 1,736 1.5 15
Serratia spp. 3,036 1.4 15 1,185 1.9 13 763 2.1 9 1,088 0.9 17
Other pathogen 38,387 17.8 10,060 15.7 5,915 16.3 22,412 19.4
Total 215,669 100.0 63,988 100.0 36,186 100.0 115,495 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Some rankings are not shown: Group B streptococci (#14, 1.4%); Cutibacterium acnes (#15, 1.3%).
  2. Some rankings are not shown: Candida glabrata (#14, 1.6%).
  3. When analyzed at the genus-level, Candida and Enterococcus spp. resulted in the following rankings:
  4. Candida – All SSIs (#6, 5.6%); superficial incision (#9, 3.0%); deep incisional (#9, 2.3%); organ/space (#4, 8.2%).
  5. Enterococcus – All SSIs (#3, 13.1%); superficial incision (#2, 11.9%); deep incisional (#3, 9.3%); organ/space (#2, 14.9%).

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. ›Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type